Cargando…

Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study

OBJECTIVES: Low serum vitamin D levels have been associated with risk for certain malignancies, but studies have not directly analysed levels between community oncology and primary care practices. The purpose of this study was to compare serum vitamin D levels in patients at a community oncology pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Churilla, Thomas M, Lesko, Samuel L, Brereton, Harmar D, Klem, Mary, Donnelly, Patrick E, Peters, Christopher A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244660/
https://www.ncbi.nlm.nih.gov/pubmed/22184590
http://dx.doi.org/10.1136/bmjopen-2011-000397
_version_ 1782219748064362496
author Churilla, Thomas M
Lesko, Samuel L
Brereton, Harmar D
Klem, Mary
Donnelly, Patrick E
Peters, Christopher A
author_facet Churilla, Thomas M
Lesko, Samuel L
Brereton, Harmar D
Klem, Mary
Donnelly, Patrick E
Peters, Christopher A
author_sort Churilla, Thomas M
collection PubMed
description OBJECTIVES: Low serum vitamin D levels have been associated with risk for certain malignancies, but studies have not directly analysed levels between community oncology and primary care practices. The purpose of this study was to compare serum vitamin D levels in patients at a community oncology practice with non-cancer patients at a primary care practice. DESIGN: Retrospective case–control study. 25-Hydroxyvitamin D levels were ordered for screening in both cancer and non-cancer patients. Levels were compared in univariate and multivariate analyses adjusted for age, body mass index and season of blood draw. SETTING: A community-based radiation oncology centre and a community-based primary care practice: both located in Northeastern Pennsylvania, USA. PARTICIPANTS: 170 newly diagnosed cancer patients referred for initial consultation at the community oncology centre from 21 November 2008 to 18 May 2010, and 170 non-cancer patients of the primary care practice who underwent screening for hypovitaminosis D for the first time from 1 January 2009 to 31 December 2009. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measure was mean serum vitamin D level, and the secondary outcome measures were frequencies of patients with vitamin D levels <20 ng/ml and levels <30 ng/ml. RESULTS: The oncology patients had a significantly lower mean serum vitamin D level (24.9 ng/ml) relative to a cohort of non-cancer primary care patients (30.6 ng/ml, p<0.001) from the same geographical region. The relationship retained significance after adjustment for age, body mass index and season of blood draw in multivariate analysis (p=0.001). Levels <20 and <30 ng/ml were more frequent in the oncology patients (OR (95% CI)=2.59 (1.44 to 4.67) and 2.04 (1.20 to 3.46), respectively) in multivariate analysis. CONCLUSIONS: Cancer patients were found to have low vitamin D levels relative to a similar cohort of non-cancer primary care patients from the same geographical region.
format Online
Article
Text
id pubmed-3244660
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-32446602012-02-28 Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study Churilla, Thomas M Lesko, Samuel L Brereton, Harmar D Klem, Mary Donnelly, Patrick E Peters, Christopher A BMJ Open Oncology OBJECTIVES: Low serum vitamin D levels have been associated with risk for certain malignancies, but studies have not directly analysed levels between community oncology and primary care practices. The purpose of this study was to compare serum vitamin D levels in patients at a community oncology practice with non-cancer patients at a primary care practice. DESIGN: Retrospective case–control study. 25-Hydroxyvitamin D levels were ordered for screening in both cancer and non-cancer patients. Levels were compared in univariate and multivariate analyses adjusted for age, body mass index and season of blood draw. SETTING: A community-based radiation oncology centre and a community-based primary care practice: both located in Northeastern Pennsylvania, USA. PARTICIPANTS: 170 newly diagnosed cancer patients referred for initial consultation at the community oncology centre from 21 November 2008 to 18 May 2010, and 170 non-cancer patients of the primary care practice who underwent screening for hypovitaminosis D for the first time from 1 January 2009 to 31 December 2009. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measure was mean serum vitamin D level, and the secondary outcome measures were frequencies of patients with vitamin D levels <20 ng/ml and levels <30 ng/ml. RESULTS: The oncology patients had a significantly lower mean serum vitamin D level (24.9 ng/ml) relative to a cohort of non-cancer primary care patients (30.6 ng/ml, p<0.001) from the same geographical region. The relationship retained significance after adjustment for age, body mass index and season of blood draw in multivariate analysis (p=0.001). Levels <20 and <30 ng/ml were more frequent in the oncology patients (OR (95% CI)=2.59 (1.44 to 4.67) and 2.04 (1.20 to 3.46), respectively) in multivariate analysis. CONCLUSIONS: Cancer patients were found to have low vitamin D levels relative to a similar cohort of non-cancer primary care patients from the same geographical region. BMJ Group 2011-12-19 /pmc/articles/PMC3244660/ /pubmed/22184590 http://dx.doi.org/10.1136/bmjopen-2011-000397 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Oncology
Churilla, Thomas M
Lesko, Samuel L
Brereton, Harmar D
Klem, Mary
Donnelly, Patrick E
Peters, Christopher A
Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study
title Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study
title_full Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study
title_fullStr Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study
title_full_unstemmed Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study
title_short Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study
title_sort serum vitamin d levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case–control study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244660/
https://www.ncbi.nlm.nih.gov/pubmed/22184590
http://dx.doi.org/10.1136/bmjopen-2011-000397
work_keys_str_mv AT churillathomasm serumvitamindlevelsamongpatientsinaclinicaloncologypracticecomparedtoprimarycarepatientsinthesamecommunityacasecontrolstudy
AT leskosamuell serumvitamindlevelsamongpatientsinaclinicaloncologypracticecomparedtoprimarycarepatientsinthesamecommunityacasecontrolstudy
AT breretonharmard serumvitamindlevelsamongpatientsinaclinicaloncologypracticecomparedtoprimarycarepatientsinthesamecommunityacasecontrolstudy
AT klemmary serumvitamindlevelsamongpatientsinaclinicaloncologypracticecomparedtoprimarycarepatientsinthesamecommunityacasecontrolstudy
AT donnellypatricke serumvitamindlevelsamongpatientsinaclinicaloncologypracticecomparedtoprimarycarepatientsinthesamecommunityacasecontrolstudy
AT peterschristophera serumvitamindlevelsamongpatientsinaclinicaloncologypracticecomparedtoprimarycarepatientsinthesamecommunityacasecontrolstudy